ERBB2 and breast cancer: The findings from this study would be strengthened with additional (similar) studies in other mouse models of HER2+ breast cancer (e.g., SKBR3, MDA-MB-361) as well as syngeneic models, such as MMTV-HER2/neu-transgenic mice.